(Q61847179)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Growth hormone and ageing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

J Svensson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B A Bengtsson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

Growth Hormone & I G F Research

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

10 Suppl B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

S25-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

The endocrinology of aging

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

A method for estimating the number of motor units in thenar muscles and the changes in motor unit count with ageing

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Physiological changes in ageing muscles

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Morphology and enzymatic capacity in arm and leg muscles in 78-81 year old men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Growth hormone. 2. Clinical use of human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Impaired growth hormone secretion in the adult population: relation to age and adiposity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Effect of a sustained program of resistance training on the acute growth hormone response to resistance exercise in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

The IGF-I response to very low rhGH doses is preserved in human ageing

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Which adults develop side-effects of growth hormone replacement?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Two years of replacement therapy in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Growth hormone and hepatic lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Body composition in growth hormone deficient adults over the age of 60 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Effects of human growth hormone in men over 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Growth hormone replacement in healthy older men improves body composition but not functional ability

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Beneficial effects of growth hormone treatment in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Nutritional support in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Peptidomimetic regulation of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

Intranasal administration of the GHRP hexarelin accelerates growth in short children

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980006-4

7 January 2021

10.1016/S1096-6374(00)80006-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984250%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference